Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
October 14, 2024 - Page 3 of 3 - The Dermatology Digest
Subscribe
Search

Day: October 14, 2024

FDA Nod for Fifth Stelara Biosimilar

The U.S. Food and Drug Administration (FDA) has approved Dong-A ST’s Imuldosa (ustekinumab-srlf/DMB-3115), a biosimilar referencing Stelara. Imuldosa is a biosimilar to Stelara which is approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. Ustekinumab blocks interleukin (IL)-12 and -23. Dong-A Socio Holdings and Meiji Seika Pharma began joint development […]